Vanberra Signal

InterVenn

Curated by Signal

Provider of an AI-based clinical decision supporting tool for cancer detection and drug development

Overview

Provider of an AI-based clinical decision supporting tool for cancer detection and drug development. The company has developed tools like Dawn which is immune-oncology testing software that uses glycoproteomics and AI. The VISTA tool assists with the quantification of proteins in serum or blood. It has features to analyze clinical biomarkers for disease diagnosis, drug development, and treatment prediction. The VOCAL is a diagnostic tool for detecting cancer in ovaries.

Key facts

Founded
2017

Business model

Contact

Open roles

2 roles
  • Director of Business Development

    South San Francisco, CA · On-site · Volunteer

  • Director, Dx Strategy & Commercialization

    South San Francisco, CA · On-site · Full-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Intravascular Ultrasound system and Contrast media injection systems for cardiological, vascular & radiological applications

    Life Sciences TechnologyEden Prairie, United States
  • Provider of body vitals monitoring and telemedicine platform

    Life Sciences TechnologySunnyvale, United States
  • Personalized supplements for women

    Life Sciences TechnologyPhiladelphia, United States

About InterVenn

What does InterVenn do?

Provider of an AI-based clinical decision supporting tool for cancer detection and drug development.

Where is InterVenn headquartered?

InterVenn is headquartered in San Francisco, United States.

When was InterVenn founded?

InterVenn was founded in 2017.

Which sector is InterVenn in?

InterVenn operates in Life Sciences Technology.

Who are InterVenn's competitors?

Companies similar to InterVenn include ACIST Medical systems, DynoSense, and BINTO.

Is InterVenn hiring?

Yes. InterVenn has 2 open roles listed on Vanberra Signal.